---
figid: PMC3481559__10.1177_1758834012454464-fig1
figlink: /pmc/articles/PMC3481559/figure/fig1-1758834012454464/
number: F1
caption: The VEGF pathway and its targets for inhibition. The interaction of VEGF-A
  with VEGFR-2 is considered the most relevant interaction for angiogenesis. VEGF-A,
  however, also interacts with VEGFR-1, as do VEGF-B and PlGF; the contribution of
  the latter two to the angiogenesis pathway and escape from angiogenesis inhibition
  is not yet fully understood. Targets for angiogenesis inhibition include VEGF ligands
  (aflibercept and bevacizumab), VEGF receptors (e.g. IMC-1121B), and tyrosine kinase
  signaling (TKIs) []. PlGF, placental growth factor; VEGF, vascular endothelial growth
  factor; VEGFR, vascular endothelial growth factor receptor.
pmcid: PMC3481559
papertitle: Antiangiogenesis therapy in the treatment of metastatic colorectal cancer.
reftext: Axel Grothey, et al. Ther Adv Med Oncol. 2012 Nov;4(6):301-319.
pmc_ranked_result_index: '27283'
pathway_score: 0.6226485
filename: 10.1177_1758834012454464-fig1.jpg
figtitle: VEGF pathway and its targets for inhibition
year: '2012'
organisms: Homo sapiens
ndex: a18a1350-df36-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3481559__10.1177_1758834012454464-fig1.html
  '@type': Dataset
  description: The VEGF pathway and its targets for inhibition. The interaction of
    VEGF-A with VEGFR-2 is considered the most relevant interaction for angiogenesis.
    VEGF-A, however, also interacts with VEGFR-1, as do VEGF-B and PlGF; the contribution
    of the latter two to the angiogenesis pathway and escape from angiogenesis inhibition
    is not yet fully understood. Targets for angiogenesis inhibition include VEGF
    ligands (aflibercept and bevacizumab), VEGF receptors (e.g. IMC-1121B), and tyrosine
    kinase signaling (TKIs) []. PlGF, placental growth factor; VEGF, vascular endothelial
    growth factor; VEGFR, vascular endothelial growth factor receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FLT4
  - KDR
  - VEGFC
  - PGF
  - PIGF
  - FLT1
  - VEGFB
  - VEGFA
  - VEGFD
  - Tyrosine
genes:
- word: VEGFR-3
  symbol: VEGFR3
  source: hgnc_alias_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: (VEGFR-2)
  symbol: VEGFR2
  source: hgnc_alias_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: VEGF-C
  symbol: VEGFC
  source: hgnc_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: PIGF
  symbol: PIGF
  source: hgnc_symbol
  hgnc_symbol: PIGF
  entrez: '5281'
- word: VEGFR-1
  symbol: VEGFR1
  source: hgnc_alias_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: VEGF-B
  symbol: VEGFB
  source: hgnc_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF-D
  symbol: VEGF-D
  source: hgnc_alias_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF-A
  symbol: VEGF-A
  source: hgnc_alias_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
chemicals:
- word: Tyrosine
  source: MESH
  identifier: D014443
diseases: []
figid_alias: PMC3481559__F1
redirect_from: /figures/PMC3481559__F1
figtype: Figure
---
